Abstract:p53 is a phosphorylated glycoprotein whose expression is abnormally elevated in various human tumors. p53 also regulates a variety of tumor cells, but research on cervical cancer has not yet been reported. This study intends to investigate the role of targeting p53 in cervical cancer. Electron microscopy was used to assess the size of protein particles, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2 H-tetrazolium bromide (MTT) was used to detect the OD value of nanocomposites at different concentrations using a UV spectrophotometer, MTT and cell cloning were used to detect cell proliferation expression ability, and reverse transcriptase polymerase chain reaction (RT-PCR) to detect p53 expression. Immunofluorescence measured nuclear factor kappa B (NF-κB) expression in cells, and western blotting assessed the relative expression of p53 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins. The detection mechanism was further explored through in vivo studies. Glutaraldehyde (GLA)-loaded liposomal albumin particles showed a positive zeta value, indicating that the CS coating process of GLA was successful. Our data show that the experimental group showed a concentration-dose-dependent growth relationship, indicating that GLA-loaded liposome albumin particles have better antitumor activity in cervical cancer cell lines. Compared with most GLA-loaded liposomal albumin particle groups, P53 expression was inhibited, and the expression of P53 was downregulated in GLA-loaded liposomal albumin particle cervical cancer. In vivo results showed that the measured tumor volume decreased after treatment with GLA-loaded liposomal albumin particles, and mice treated with GLA-loaded liposomal albumin particles had longer survival times. Induction of NF-κB in tumors may be a powerful strategy allowing GLA-loaded liposomal albumin particles to avoid apoptosis and possibly after cytotoxic chemotherapy. This study demonstrates that GLA-loaded liposomal albumin particles may participate in the development and progression of human cervical cancer cells by targeted regulation of NF-κB activity.

Inhibition of Monoacylglycerol Lipase Restrains Proliferation, Migration, Invasion, Tumor Growth and Induces Apoptosis in Cervical Cancer.

Effect of monoacylglycerol lipase on the tumor growth in endometrial cancer

Monoacylglycerol Lipase (MAGL) Knockdown Inhibits Tumor Cells Growth in Colorectal Cancer

Monoacylglycerol Lipase Inhibitor JZL184 Regulates Apoptosis and Migration of Colorectal Cancer Cells.

Transgelin 2 Overexpression Inhibits Cervical Cancer Cell Invasion and Migration.

Monoacylglycerol Lipase Promotes Progression of Hepatocellular Carcinoma Via NF-κB-mediated Epithelial-Mesenchymal Transition

Monoacylglycerol Lipase Knockdown Inhibits Cell Proliferation and Metastasis in Lung Adenocarcinoma

The Effects of Monoacylglycerol Lipase on M2-like Tumor-Associated Macrophages-Induced Lung Metastasis of MHCC97H Cells

[Effect of Monoacylglycerol Lipase with Proliferation of MHCC97H Human Liver Cancer Cells in Vivo].

Monoacylglycerol Lipase Promotes Metastases in Nasopharyngeal Carcinoma.

Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders

The Natural Compound Magnolol Inhibits Invasion and Exhibits Potential in Human Breast Cancer Therapy

Magnolol Exerts Anticancer Activity in Hepatocellular Carcinoma Cells Through Regulating Endoplasmic Reticulum Stress-Mediated Apoptotic Signaling

ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL

A carrier free delivery system of a MAGL inhibitor is effective on ovarian cancer

MAGI1 Inhibits Migration and Invasion Via Blocking MAPK/ERK Signaling Pathway in Gastric Cancer.

GLA-loaded Liposome Albumin Particles-mediated p53 Targets Cervical Cancer Cell Transplant Tumors

Magnolol Suppresses Pancreatic Cancer Development in Vivo and in Vitro Via Negatively Regulating TGF-β/Smad Signaling

Down-expression of GOLM1 Enhances the Chemo-Sensitivity of Cervical Cancer to Methotrexate Through Modulation of the MMP13/EMT Axis

Abx-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by regulating the mgll-ros/akr1c1 pathway

GSK3B inhibition reduced cervical cancer cell proliferation and migration by modulating the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition